Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abide, abovementioned, Adagene, adjunct, AIHA, AITL, Angioimmunoblastic, antiangiogenic, Anticancer, antitrust, API, argue, asthenia, augment, BC, Boao, BOC, bozitinib, CANbridge, ccRCC, CFC, chemotherapeutic, CMML, combo, commissioner, costimulatory, CRL, customary, cut, deeply, defense, destination, diagram, digestive, divulged, Divulgence, domiciled, dynamic, eat, eleven, emphasized, emphasizing, endanger, enlisted, Erroneously, ES, escape, evorpacept, Fujian, fungible, gazetted, globe, guideline, Hainan, heard, hemagglutination, heritage, Huatai, hub, hydrochloride, idelalisib, illustrating, immunogenicity, inaugurated, inclined, incomplete, Inland, Institutionalization, interventional, introduction, Ipsen, jeopardize, JTO, Lecheng, Lefei, lemzoparlimab, lift, lifted, linperlisib, magrolimab, MedTech, Michael, Michigan, Mindray, Ming, missing, mistakenly, MRCT, MTD, multiregional, myelomonocytic, NHSA, NIH, Ocumension, Omicron, outbound, path, PhD, PhIb, postdoctoral, postgraduate, predominantly, pro, proactively, Proffered, PRZD, psychiatry, Pudong, ramucirumab, rata, red, reinforce, remote, reopened, reposition, Respir, revitalization, Rezlidnia, rigid, Roth, sanction, Sanming, SAS, savolitnib, Scrutinizing, Sep, shi, shut, SIRP, solvent, steady, stricter, Subpart, Sun, superfamily, Tazemetost, telemecine, till, TNFR, tourism, Transcenta, transmembrane, truthful, Tsinghua, ubiquitously, undermine, USCACA, weak
Removed:
accrual, acknowledged, AMG, appetite, approaching, Banlangen, biopsy, bleach, Bozhou, calculating, capecitabine, causality, child, christian, circulating, Cleaning, confirm, congestion, cooperative, counter, curve, delivered, detergent, ECOG, efficiency, eighty, elucidate, emergent, epithelia, epitinib, explicitly, exploration, extrapancreatic, fever, FLAURA, footprint, Fu, Gemzar, generalized, great, Han, harbored, headcount, hogg, hypersensitivity, India, intentionally, intestinal, intolerant, intuitively, JY, kg, landscape, Laundry, leaving, living, longest, LV, macroglobulinemia, margin, maternal, maximizing, meantime, NaN, nest, North, Notwithstanding, NR, observable, occurring, onsite, opened, orderly, originating, osimertinib, oversaw, penetrate, perforation, permeability, prepaid, preventive, prone, remission, rental, revolutionized, routine, seasonality, Sequist, Singapore, spot, standpoint, stomach, survive, tailored, Tarceva, Taxol, Tennessee, theliatinib, tolerate, umbralisib, unsatisfactory, upside, vast, viral, Waldenstrom, week, weighed, weighing
Filing tables
Filing exhibits
HCM similar filings
Filing view
External links
Exhibit 15.4
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-240180, No. 333-224391 and No.333-212406) and Form F-3 (No. 333-237574) of HUTCHMED (China) Limited of our report dated December 7, 2021 relating to the financial statements of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, which appears in this Annual Report on Form 20-F.
/s/ PricewaterhouseCoopers Zhong Tian LLP
Guangzhou, the People’s Republic of China
February 28, 2023